Role of human hypoxanthine guanine phosphoribosyltransferase in activation of the antiviral agent T-705 (favipiravir)
about
Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic feverThe Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug DesignMulti-Omics Studies towards Novel Modulators of Influenza A Virus-Host InteractionProgress of small molecular inhibitors in the development of anti-influenza virus agents.Favipiravir (T-705), a novel viral RNA polymerase inhibitor.Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis.Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters.Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.Understanding the Mechanism of the Broad-Spectrum Antiviral Activity of Favipiravir (T-705): Key Role of the F1 Motif of the Viral Polymerase.Synthesis of T-705-Ribonucleoside and T-705-Ribonucleotide and Studies of Chemical Stability.Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis.Successful treatment of Marburg virus with orally administrated T-705 (Favipiravir) in a mouse model.Nucleobases and corresponding nucleosides display potent antiviral activities against dengue virus possibly through viral lethal mutagenesis.The mechanism of resistance to favipiravir in influenza
P2860
Q27457152-c065f68b-4b3f-6a17-a085-bee5d9d4501dQ28071809-B0983886-8E3D-4998-B0FB-3050CF763B35Q28073474-C33749AA-5168-409E-B0B2-C2306DBFC1BDQ30234943-0C1C385D-E304-40F6-B3EE-C7A678D5DB5AQ34374652-B0009984-9301-4E65-A9CD-7FE226BD69B0Q36705853-E0961FE4-8B85-4A48-9C64-D5328D8E9D10Q37120083-0769ABAC-DDB4-45BE-A927-EB6BA06A79A0Q37683496-7AF37849-82A2-4A38-993A-A6B3979EB19EQ40255981-464885E9-D969-460D-9A1E-EA6F8AFD08C2Q40282386-7991DFB5-AC5A-4792-B48A-9E81A4A728B3Q40559394-F5235A92-704D-43F9-919E-99CDA735D89CQ47548961-0667E081-9B9A-4D9E-ABBD-882E66C8F637Q54232437-FB809802-3F1D-4141-8949-6539FE348414Q57799444-9815D383-3B97-442A-981C-CDFDA5ADEFDD
P2860
Role of human hypoxanthine guanine phosphoribosyltransferase in activation of the antiviral agent T-705 (favipiravir)
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Role of human hypoxanthine gua ...... iral agent T-705 (favipiravir)
@ast
Role of human hypoxanthine gua ...... iral agent T-705 (favipiravir)
@en
Role of human hypoxanthine gua ...... iral agent T-705 (favipiravir)
@nl
type
label
Role of human hypoxanthine gua ...... iral agent T-705 (favipiravir)
@ast
Role of human hypoxanthine gua ...... iral agent T-705 (favipiravir)
@en
Role of human hypoxanthine gua ...... iral agent T-705 (favipiravir)
@nl
prefLabel
Role of human hypoxanthine gua ...... iral agent T-705 (favipiravir)
@ast
Role of human hypoxanthine gua ...... iral agent T-705 (favipiravir)
@en
Role of human hypoxanthine gua ...... iral agent T-705 (favipiravir)
@nl
P2093
P50
P3181
P356
P1476
Role of human hypoxanthine gua ...... iral agent T-705 (favipiravir)
@en
P2093
André B P van Kuilenburg
Dianne T Keough
Judith Meijer
P304
P3181
P356
10.1124/MOL.113.087247
P577
2013-10-01T00:00:00Z